reference/5454643

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5454643

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1756-9966 0392-9078
issueIdentifier	1
pageRange	88-
publicationName	Journal of experimental & clinical cancer research : CR
startingPage	88
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_30909f0d09b911b72e9d9489f51cb8ab
bibliographicCitation	Yu S, Wang L, Che D, Zhang M, Li M, Naito M, Xin W, Zhou L. Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling. Journal of Experimental & Clinical Cancer Research. 2022 Mar 08;41(1):88. doi: 10.1186/s13046-022-02261-0.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d289c80337f0022343615134caa09291 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f631993d4a5eebcd66ae984a2e70277 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8041c85f56f07146782e5a2be5896f6f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ed5ed6ebd7bca1be56a0a7072a6e9d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_649511364b1e5c5d44116eaf7203929f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1d976d03abb16da83e2a2788502d21c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ab399094e8c05a0254a8a4dfcccdb19 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_881a0dbb2dead187da6521cda273f049
date	2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1186/s13046-022-02261-0 https://pubmed.ncbi.nlm.nih.gov/PMC8903155 https://pubmed.ncbi.nlm.nih.gov/35260193
isPartOf	https://portal.issn.org/resource/ISSN/1756-9966 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20601 https://portal.issn.org/resource/ISSN/0392-9078
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling
discusses	http://id.nlm.nih.gov/mesh/M0004268 http://id.nlm.nih.gov/mesh/M0150739 http://id.nlm.nih.gov/mesh/M0220800 http://id.nlm.nih.gov/mesh/M0027390
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_effabf75f87a02358f0a8868edaf2c9f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_467b750f9a6073f1098d1aa6270e135d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_42a006086ba41a0d45629340b4b8c166 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10906 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_744117db1e81ab1e4aebb6f186b13f7d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5f8f19d61252fdce5cae1f415ad035b2 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.22.56 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_10cdb76d9c0c9f2914000d240a68700d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a78038e865c91b8a310aff2ee0fe6e24 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2e87082b1b99acb24211d583d5b8ec8b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8d4994a132beee9c32c8d7d7b2f34a93

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1382

Total number of triples: 55.